4.6 Review

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy

Related references

Note: Only part of the references are listed.
Review Neurosciences

Neurotoxicity of MDMA: Main effects and mechanisms

Giulia Costa et al.

Summary: Studies suggest that MDMA, commonly known as 'ecstasy', not only has abuse potential, but may also cause acute and persistent central level abnormalities with demonstrated neurotoxic effects in experimental animals. This could pose serious health risks since MDMA is frequently used recreationally by young and adult individuals.

EXPERIMENTAL NEUROLOGY (2022)

Review Clinical Neurology

Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self-transcendence, and therapeutic relationships

Jason B. Luoma et al.

Summary: Researchers suggest that adding MDMA to psychotherapy may enhance treatment outcomes for disorders like social anxiety disorder by potentially enhancing memory reconsolidation, inducing self-transcendent experiences, and improving therapeutic relationships.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2022)

Review Pharmacology & Pharmacy

MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis

Kimberly W. Smith et al.

Summary: This article discusses the use of MDMA-assisted psychotherapy in treating PTSD, showing that it is effective in reducing CAPS scores but also carries risks.

JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Neurosciences

MDMA and memory, addiction, and depression: dose-effect analysis

Madeline M. Pantoni et al.

Summary: This study aims to verify the conclusion from our previous systematic review that 3 mg/kg may be the threshold for MDMA-induced amnesia, and to further understand the dose-effect relationship of MDMA on behavioral assays of memory, addiction, and depression.

PSYCHOPHARMACOLOGY (2022)

Review Clinical Neurology

Review of potential psychedelic treatments for PTSD

Ryan L. Henner et al.

Summary: This paper reviews the mechanism of action, clinical evidence, safety, and side effects of MDMA and classical psychedelics in treating PTSD. Although there is no direct clinical evidence for classical psychedelics in treating PTSD, the existing studies support the need for further research. However, the small sample sizes and strict participant selection in the studies highlight the need for more research to validate the feasibility of psychedelic-assisted treatment for PTSD.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

Article Biotechnology & Applied Microbiology

The promises and perils of psychedelic pharmacology for psychiatry

Tristan D. McClure-Begley et al.

Summary: Psychedelic drugs have emerging therapeutic potential for neuropsychiatric diseases, but there are still many challenges and uncertainties. Further research is needed to understand the mechanisms of action and develop cleaner drugs to fully realize their therapeutic potential.

NATURE REVIEWS DRUG DISCOVERY (2022)

Review Psychiatry

Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated

David E. Nichols

Summary: At first glance, the molecular structures of MDMA and MDA seem similar, but their activity stereochemistry differs. MDMA is distinct from classical hallucinogenic phenethylamines in structure and psychopharmacology. It promotes affiliative social behavior, has acute anxiolytic effects, and induces introspection and personal reflection. Its mechanism of action involves the transport and release of neuronal serotonin.

FRONTIERS IN PSYCHIATRY (2022)

Review Medicine, General & Internal

Unraveling the Mysteries of Mental Illness With Psilocybin

Robert Sotille et al.

Summary: Current medications have not been effective in reducing the prevalence of mental illness worldwide. However, transcranial magnetic stimulation and ketamine therapy are showing promise in treating treatment-resistant depression. New psychotherapeutics targeting underlying cellular pathologies are needed. Psychedelics, such as psilocybin, are gaining renewed interest as potential therapeutic molecules for mental illness.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Psychology, Clinical

Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder

Linnae Ponte et al.

Summary: This study demonstrates the beneficial effects of MDMA-assisted psychotherapy in improving sleep quality and reducing symptoms in individuals with PTSD during treatment.

JOURNAL OF TRAUMATIC STRESS (2021)

Article Clinical Neurology

Suicide risk in people with post-traumatic stress disorder: A cohort study of 3.1 million people in Sweden

Verity Fox et al.

Summary: The study found that individuals with PTSD in the general population in Sweden had higher suicide rates regardless of sex, and if causal, 1.6% of general population suicides could be attributed to PTSD.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Review Clinical Neurology

Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy

Hans Emanuel Oeri

Summary: MDMA is currently the only compound actively investigated as a medicine, but the lack of alternatives may be detrimental to patients who do not respond well to its mechanism of action or require modification of its effects. Therefore, compounds from different classes are identified as potential alternatives to MDMA.

JOURNAL OF PSYCHOPHARMACOLOGY (2021)

Review Psychiatry

Functional impairment in Posttraumatic Stress Disorder: A systematic review and meta-analysis

Lena Jellestad et al.

Summary: Research has shown that individuals with Posttraumatic Stress Disorder (PTSD) experience impairments in various functional domains, with significant effects compared to healthy individuals. This suggests that PTSD has a significant impact on daily functioning, highlighting the importance of early detection and targeted treatment for functional deficits in this patient population.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

Review Pharmacology & Pharmacy

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Antonio Inserra et al.

Summary: Psychedelic compounds are emerging as potential novel therapeutics in psychiatry, with their main effects mediated through the modulation of neurotransmitter systems, immunity, and neuroplasticity. Promising results suggest an opportunity for improvement in the treatment of psychiatric disorders, an area that has seen limited advancement in the past 20 years. Studies are underway to separate the psychedelic effects from the therapeutic effects of these compounds, aiming to provide more effective treatment options.

PHARMACOLOGICAL REVIEWS (2021)

Review Health Care Sciences & Services

The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges

Rafael Guimaraes dos Santos et al.

Summary: Psychedelics act by agonizing serotonergic 5-HT2A receptors, leading to changes in perception, cognitive processes, and mood. Despite historical use in ritual contexts, these substances have gained interest in science and industry for their potential antidepressant, anxiolytic, and antiaddictive effects.

RISK MANAGEMENT AND HEALTHCARE POLICY (2021)

Review Neurosciences

Serotonergic Psychedelics in Neural Plasticity

Kacper Lukasiewicz et al.

Summary: Classical serotonergic psychedelics can induce therapeutic effects by promoting neural plasticity.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Jennifer M. Mitchell et al.

Summary: The results demonstrate that MDMA-assisted therapy is safe and effective in treating severe post-traumatic stress disorder. Compared with placebo, MDMA significantly reduces CAPS-5 scores and improves functional impairment.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Moderating Effects of BDNF Genetic Variants and Smoking on Cognition in PTSD Veterans

Gordana Nedic Erjavec et al.

Summary: This study found that cognitive dysfunction in PTSD patients is closely related to diagnosis, BDNF rs56164415 gene, and smoking. BDNF rs56164415 T allele is more common in PTSD patients and associated with cognitive decline.

BIOMOLECULES (2021)

Article Nursing

CE: Psychedelic-Assisted Therapy

Andrew Penn et al.

AMERICAN JOURNAL OF NURSING (2021)

Article Pharmacology & Pharmacy

Pharmacology of Drugs Used as Stimulants

James R. Docherty et al.

Summary: The effects of psychostimulants involve various neurotransmitter pathways and can lead to serious adverse events, including potentially life-threatening hyperthermia. Recreational users should be aware of the dangers associated with these substances.

JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Review Psychology, Clinical

A meta-analysis of dropout from evidence-based psychological treatment for post-traumatic stress disorder (PTSD) in children and young people

Caroline Simmons et al.

Summary: Despite concerns about retraumatizing patients, evidence-based treatments for PTSD in children and young people do not lead to higher dropout rates than non-trauma focused treatments. Group delivery and non-professional delivery methods are associated with lower dropout rates.

EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY (2021)

Review Medicine, General & Internal

The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis

Sarah Tedesco et al.

Summary: This study analyzes the therapeutic effects of MDMA on PTSD, showing promising evidence of its positive impact when used in conjunction with psychotherapy. Adverse events are also presented and discussed, with the comparison of beneficial and adverse events helping to identify treatment-resistant patients who may benefit from clinical trials of MDMA.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Review Neurosciences

Dopamine in Fear Extinction

Ximena I. Salinas-Hernandez et al.

Summary: This review article highlights the crucial role dopamine plays in mediating different phases of fear extinction, emphasizing the formation of extinction memories and the regulatory role of the dopamine system in fear extinction. Future research should focus on these emerging concepts and outstanding questions.

FRONTIERS IN SYNAPTIC NEUROSCIENCE (2021)

Review Psychology, Clinical

Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches

Mathew D. Hoskins et al.

Summary: The systematic review and meta-analysis found that certain medications, such as SSRIs, have a small positive effect on reducing PTSD symptom severity. Pharmacological augmentation with medications like prazosin and risperidone also shows some effectiveness in reducing symptoms. There was no evidence of superiority for one intervention over another in head-to-head comparison studies.

EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY (2021)

Review Psychology, Clinical

Pharmacological-assisted Psychotherapy for Post-Traumatic Stress Disorder: a systematic review and meta-analysis

Mathew D. Hoskins et al.

Summary: The study found that MDMA-assisted therapy showed significant superiority in reducing PTSD symptoms, while there was lack of evidence to support the efficacy of other drug-assisted interventions.

EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY (2021)

Review Psychology, Clinical

Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin

Tracey Varker et al.

Summary: This systematic review examined the efficacy of MDMA, ketamine, LSD, and psilocybin for PTSD treatment, finding that the evidence for MDMA combined with psychotherapy as a treatment for PTSD was the most reliable.

JOURNAL OF PSYCHOACTIVE DRUGS (2021)

Editorial Material Neurosciences

MDMA-assisted psychotherapy for posttraumatic stress disorder: A promising novel approach to treatment

Eric Vermetten et al.

NEUROPSYCHOPHARMACOLOGY (2020)

Article Behavioral Sciences

Learning-induced intrinsic and synaptic plasticity in the rodent medial prefrontal cortex

James T. Porter et al.

NEUROBIOLOGY OF LEARNING AND MEMORY (2020)

Review Clinical Neurology

Reviewing the Potential of Psychedelics for the Treatment of PTSD

Erwin Krediet et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)

Review Multidisciplinary Sciences

Function and mechanisms of memory destabilization and reconsolidation after retrieval

Satoshi Kida

PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2020)

Review Neurosciences

The Role of BDNF on Neural Plasticity in Depression

Yang Tao et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Review Neurosciences

PTSD-related neuroimaging abnormalities in brain function, structure, and biochemistry

Nathaniel G. Harnett et al.

EXPERIMENTAL NEUROLOGY (2020)

Review Cell Biology

Neurotrophin signalling in amygdala-dependent cued fear learning

Susanne Meis et al.

CELL AND TISSUE RESEARCH (2020)

Article Psychiatry

The association of PTSD symptom severity with amygdala nuclei volumes in traumatized youths

Olga Therese Ousdal et al.

TRANSLATIONAL PSYCHIATRY (2020)

Review Medicine, General & Internal

Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review

Gjumrakch Aliev et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Neurosciences

MDMA and the Brain: A Short Review on the Role of Neurotransmitters in Neurotoxicity

Nor Suliana Mustafa et al.

BASIC AND CLINICAL NEUROSCIENCE (2020)

Review Psychology, Clinical

Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis

Catrin Lewis et al.

EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY (2020)

Article Psychology, Multidisciplinary

Reduced Memory Coherence for Negative Events and Its Relationship to Posttraumatic Stress Disorder

James A. Bisby et al.

CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE (2020)

Review Pharmacology & Pharmacy

The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder

Chadi G. Abdallah et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)

Editorial Material Psychiatry

Current status of psychedelic therapy in Australia and New Zealand: Are we falling behind?

Antonio Inserra

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2019)

Review Pharmacology & Pharmacy

Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System

Sebastiano Alfio Torrisi et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Psychiatry

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy

Ben Sessa et al.

FRONTIERS IN PSYCHIATRY (2019)

Review Neurosciences

Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain

Magdalena Miranda et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2019)

Review Neurosciences

Neurochemical and molecular mechanisms underlying the retrieval-extinction effect

Emma N. Cahill et al.

PSYCHOPHARMACOLOGY (2019)

Review Neurosciences

Mechanisms of fear learning and extinction: synaptic plasticity-fear memory connection

Natalia V. Luchkina et al.

PSYCHOPHARMACOLOGY (2019)

Article Cell Biology

Distinct neural mechanisms for the prosocial and rewarding properties of MDMA

Boris D. Heifets et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Psychology, Multidisciplinary

Traumatic Stress Produces Delayed Alterations of Synaptic Plasticity in Basolateral Amygdala

Huan-Huan Zhang et al.

FRONTIERS IN PSYCHOLOGY (2019)

Article Neurosciences

Psychedelic drugs-a new era in psychiatry?

David Nutt

DIALOGUES IN CLINICAL NEUROSCIENCE (2019)

Article Psychology, Clinical

Fear extinction learning improvement in PTSD after EMDR therapy: an fMRI study

Pierre-Francois Rousseau et al.

EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY (2019)

Review Biochemistry & Molecular Biology

Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine

Lee E. Dunlap et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Review Clinical Neurology

MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?

Allison A. Feduccia et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)

Article Cell Biology

Psychedelics Promote Structural and Functional Neural Plasticity

Calvin Ly et al.

CELL REPORTS (2018)

Article Pharmacology & Pharmacy

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development

Eduardo Ekman Schenberg

FRONTIERS IN PHARMACOLOGY (2018)

Review Behavioral Sciences

Memory Control: A Fundamental Mechanism of Emotion Regulation

Haakon G. Engen et al.

TRENDS IN COGNITIVE SCIENCES (2018)

Review Behavioral Sciences

Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions

Laura E. Watkins et al.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2018)

Article Psychology, Clinical

Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder

Sascha B. Thal et al.

JOURNAL OF CONTEMPORARY PSYCHOTHERAPY (2018)

Review Medicine, General & Internal

Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders

Sydney T. Osland et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Article Clinical Neurology

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy

Mark T. Wagner et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2017)

Article Behavioral Sciences

Extinction after fear memory reactivation fails to eliminate renewal in rats

Travis D. Goode et al.

NEUROBIOLOGY OF LEARNING AND MEMORY (2017)

Review Multidisciplinary Sciences

What constitutes the prefrontal cortex?

Marie Carlen

SCIENCE (2017)

Article Medicine, General & Internal

The Impact of the Brain-Derived Neurotrophic Factor Gene on Trauma and Spatial Processing

Jessica K. Miller et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Review Psychology, Multidisciplinary

The Influences of Emotion on Learning and Memory

Chai M. Tyng et al.

FRONTIERS IN PSYCHOLOGY (2017)

Review Psychology, Multidisciplinary

Posttraumatic Stress Disorder in the DSM-5: Controversy, Change, and Conceptual Considerations

Anushka Pai et al.

BEHAVIORAL SCIENCES (2017)

Article Pharmacology & Pharmacy

Potential Psychiatric Uses for MDMA

B. B. Yazar-Klosinski et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)

Review Neurosciences

Stress and Fear Extinction

Stephen Maren et al.

NEUROPSYCHOPHARMACOLOGY (2016)

Review Biochemistry & Molecular Biology

Retrieving fear memories, as time goes by ...

F. H. Do Monte et al.

MOLECULAR PSYCHIATRY (2016)

Review Behavioral Sciences

The centrality of fear extinction in linking risk factors to PTSD: A narrative review

Daniel V. Zuj et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)

Article Pharmacology & Pharmacy

Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters

Walter Sandtner et al.

MOLECULAR PHARMACOLOGY (2016)

Review Geriatrics & Gerontology

Is Post-Traumatic Stress Disorder Associated with Premature Senescence? A Review of the Literature

James B. Lohr et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2015)

Article Medicine, General & Internal

Psychedelic medicine: a re-emerging therapeutic paradigm

Kenneth W. Tupper et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2015)

Article Neurosciences

Revisiting the Role of Infralimbic Cortex in Fear Extinction with Optogenetics

Fabricio H. Do-Monte et al.

JOURNAL OF NEUROSCIENCE (2015)

Review Behavioral Sciences

The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals

Philip Kamilar-Britt et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)

Review Medicine, General & Internal

Post-traumatic stress disorder

Jonathan I. Bisson et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Review Medicine, General & Internal

Post-traumatic stress disorder

Jonathan I. Bisson et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Article Psychiatry

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning

M. B. Young et al.

TRANSLATIONAL PSYCHIATRY (2015)

Article Neurosciences

MDMA: a social drug in a social context

Matthew G. Kirkpatrick et al.

PSYCHOPHARMACOLOGY (2015)

Review Psychiatry

Posttraumatic Stress Disorder in Adults: Impact, Comorbidity, Risk Factors, and Treatment

Jitender Sareen

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2014)

Article Neurosciences

MDMA enhances emotional empathy and prosocial behavior

Cedric M. Hysek et al.

SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2014)

Article Neurosciences

'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content

Margaret C. Wardle et al.

SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2014)

Article Psychology, Clinical

Finalizing PTSD in DSM-5: Getting Here From There and Where to Go Next

Matthew J. Friedman

JOURNAL OF TRAUMATIC STRESS (2013)

Article Psychiatry

Amygdala Volume Changes in Posttraumatic Stress Disorder in a Large Case-Controlled Veterans Group

Rajendra A. Morey et al.

ARCHIVES OF GENERAL PSYCHIATRY (2012)

Review Psychiatry

Stigma in attention deficit hyperactivity disorder

Anna K. Mueller et al.

ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS (2012)

Article Neurosciences

Could MDMA be useful in the treatment of post-traumatic stress disorder?

Ben Sessa

PROGRESS IN NEUROLOGY AND PSYCHIATRY (2011)

Review Chemistry, Medicinal

Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation

Elena Puerta et al.

PHARMACEUTICALS (2011)

Editorial Material Substance Abuse

Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin

Udo Benzenhoefer et al.

ADDICTION (2010)

Article Neurosciences

Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder

Mohammed R. Milad et al.

BIOLOGICAL PSYCHIATRY (2009)

Review Clinical Neurology

Posttraumatic Stress Disorder: The Role of Medial Prefrontal Cortex and Amygdala

Michael Koenigs et al.

NEUROSCIENTIST (2009)

Article Neurosciences

Effects of MDMA on sociability and neural response to social threat and social reward

Gillinder Bedi et al.

PSYCHOPHARMACOLOGY (2009)

Article Medical Laboratory Technology

Human pharmacology of MDMA -: Pharmacokinetics, metabolism, and disposition

R de la Torre et al.

THERAPEUTIC DRUG MONITORING (2004)